在晚期卵巢癌中NACT的选择性优势:回顾性单中心分析
Adrienne Szilvia Berczi1, Olivér Lampé1, Zoárd Tibor Krasznai1
1Department of Obstetrics and Gynecology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Medicina (Kaunas, Lithuania)
|August 28, 2025
概括
与初级除手术相比,经过间隔除手术 (NACT + IDS) 的新辅助化疗导致晚期卵巢癌患者的手术不那么复杂和更短. 在两组中实现了完全的瘤切除后,生存结果相似.
科学领域:
- 妇科瘤学
- 外科瘤学
- 化疗研究
背景情况:
- 晚期上皮卵巢癌 (EOC) 的预后不佳.
- 完整的宏观细胞减少是EOC的主要可修改的生存预测因子.
- 新辅助化疗 (NACT) 随后的间隔除手术 (IDS) 是高瘤负担EOC的替代方案,但其手术复杂性仍有争议.
研究的目的:
- 为了比较 NACT + IDS 和初级卸载手术 (PDS) 之间的手术特征和生存结果.
- 通过使用标准化指标在现实环境中评估手术复杂性.
- 确定NACT+IDS与PDS对无进展生存 (PFS) 和整体生存 (OS) 的影响.
主要方法:
- 在47名FIGO IIIC- IV高度血清性EOC患者的回顾性分析中.
- 在接受NACT+IDS的25名患者和接受PDS的22名患者之间进行比较.
- 通过外科复杂度评分 (SCS) 和通过腹腔癌指数 (PCI) 的瘤负担量化;使用卡普兰-梅尔和考克斯模型的生存分析.
主要成果:
- NACT + IDS的完全细胞减少率为76%,而PDS的完全细胞减少率为68%.
- NACT + IDS 组的平均手术复杂性显著降低 (SCS 5. 0 与 6. 2) 和手术时间 (140 与 197 分钟).
- 血流,并发症或住院时间没有显著差异;中位数的PFS为25个月 (NACT + IDS) 与21个月 (PDS),不具有统计学意义.
结论:
- 在精选的高级EOC患者中,NACT+IDS与较短和较少复杂的手术有关.
- 在实现完整的细胞减少 (R0) 时,NACT + IDS和PDS的生存结果是可比的.
- 选择性使用NACT + IDS可能适用于患有广泛疾病或健康状况不佳的患者,强调完全的细胞减少作为关键的预后因素.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448


